Literature DB >> 29301843

Cell Therapy for Nonischemic Cardiomyopathy: Current Status and Future Perspectives.

Bojan Vrtovec1.   

Abstract

Entities:  

Keywords:  bone marrow; cardiomyopathy, dilated; cell- and tissue-based therapy; heart failure; humans

Mesh：

Year:  2018        PMID： 29301843     DOI： 10.1161/CIRCRESAHA.117.312385

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  5 in total

Review 1.  Injectable Hydrogels for Improving Cardiac Cell Therapy-In Vivo Evidence and Translational Challenges.

Authors:  Cecilie Hoeeg; Alireza Dolatshahi-Pirouz; Bjarke Follin
Journal:  Gels       Date:  2021-01-22

Review 2.  Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.

Authors:  Cecilie Hoeeg; Sabina Frljak; Abbas Ali Qayyum; Bojan Vrtovec; Jens Kastrup; Annette Ekblond; Bjarke Follin
Journal:  Biomedicines       Date:  2020-12-05

3.  Stem cell therapy for dilated cardiomyopathy.

Authors:  Rienzi Diaz-Navarro; Gerard Urrútia; John Gf Cleland; Daniel Poloni; Francisco Villagran; Roberto Acosta-Dighero; Shrikant I Bangdiwala; Gabriel Rada; Eva Madrid
Journal:  Cochrane Database Syst Rev       Date:  2021-07-21

Review 4.  Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach.

Authors:  Job A J Verdonschot; Mark R Hazebroek; James S Ware; Sanjay K Prasad; Stephane R B Heymans
Journal:  J Am Heart Assoc       Date:  2019-06-01       Impact factor: 5.501

5.  Therapeutic efficacy of shenmai injection as an adjuvant treatment in dilated cardiomyopathy: A protocol for systematic review.

Authors:  Kai Gao; Yan-Ping Song; Anna Song; Hao Chen; Lin-Tao Zhao; Hai-Wang Zhang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.